{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:13:26Z","timestamp":1791825206109,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1R01DK098414"],"award-info":[{"award-number":["1R01DK098414"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P20 RR021940"],"award-info":[{"award-number":["P20 RR021940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32ES007079-34"],"award-info":[{"award-number":["T32ES007079-34"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000139","name":"U.S. Environmental Protection Agency","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.taap.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T15:51:05Z","timestamp":1462290665000},"page":"18-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction"],"prefix":"10.1016","volume":"304","author":[{"given":"Kevin M.","family":"Beggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"McGreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumedha","family":"Gunewardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0794-2263","authenticated-orcid":false,"given":"Jed N.","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoper","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6741-7164","authenticated-orcid":false,"given":"Udayan","family":"Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2016.05.001_bb0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/toxsci\/kfm110","article-title":"Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha","volume":"98","author":"Abbott","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2016.05.001_bb0010","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jcc.23905","article-title":"DOCK 6: impact of new features and current docking performance","volume":"36","author":"Allen","year":"2015","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.taap.2016.05.001_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/toxsci\/kft226","article-title":"Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction","volume":"137","author":"Beggs","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2016.05.001_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1172\/JCI0216076","article-title":"Human CYP7A1 deficiency: progress and enigmas","volume":"110","author":"Beigneux","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2016.05.001_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tox.2008.06.007","article-title":"Perfluorooctane sulfonate-induced changes in fetal rat liver gene expression","volume":"251","author":"Bjork","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2016.05.001_bb0030","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1074\/jbc.M111.334599","article-title":"Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4alpha in adult mice","volume":"287","author":"Bonzo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2016.05.001_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2015.04.004","article-title":"Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes","volume":"333","author":"Buhrke","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2016.05.001_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2012.01.003","article-title":"Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats","volume":"293","author":"Butenhoff","year":"2012","journal-title":"Toxicology"},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2016.05.001_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2014.905767","article-title":"A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans","volume":"44","author":"Chang","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/713608371","article-title":"The human relevance of information on carcinogenic modes of action: overview","volume":"33","author":"Cohen","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPARalpha) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0060","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1242\/dev.062547","article-title":"HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells","volume":"138","author":"DeLaForest","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.taap.2016.05.001_bb0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/10408440802209804","article-title":"Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha","volume":"39","author":"DeWitt","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0070","first-page":"179","article-title":"Perfluorinated substances in human food and other sources of human exposure","volume":"208","author":"D'Hollander","year":"2010","journal-title":"Rev. Environ. Contam. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.envint.2011.08.001","article-title":"Health risks of dietary exposure to perfluorinated compounds","volume":"40","author":"Domingo","year":"2012","journal-title":"Environ. Int."},{"key":"10.1016\/j.taap.2016.05.001_bb0080","doi-asserted-by":"crossref","first-page":"23311","DOI":"10.1074\/jbc.M400864200","article-title":"Structural basis for HNF-4alpha activation by ligand and coactivator binding","volume":"279","author":"Duda","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2016.05.001_bb0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0959-440X(02)00344-5","article-title":"Rotamer libraries in the 21st century","volume":"12","author":"Dunbrack","year":"2002","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.taap.2016.05.001_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tox.2011.12.014","article-title":"Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARalpha and CAR\/PXR","volume":"293","author":"Elcombe","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2016.05.001_bb0095","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.jom.0000232486.07658.74","article-title":"Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources","volume":"48","author":"Emmett","year":"2006","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.taap.2016.05.001_bb0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ecoenv.2014.04.039","article-title":"Associations between serum concentrations of perfluoroalkyl acids and serum lipid levels in a Chinese population","volume":"106","author":"Fu","year":"2014","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.taap.2016.05.001_bb0105","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2016.05.001_bb0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.chemosphere.2013.10.005","article-title":"The association between PFOA, PFOS and serum lipid levels in adolescents","volume":"98","author":"Geiger","year":"2014","journal-title":"Chemosphere"},{"key":"10.1016\/j.taap.2016.05.001_bb0115","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1582-4934.2011.01289.x","article-title":"Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis","volume":"16","author":"Georges","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.taap.2016.05.001_bb0120","first-page":"1","article-title":"Aquatic toxicology of perfluorinated chemicals","volume":"202","author":"Giesy","year":"2010","journal-title":"Rev. Environ. Contam. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.pharmthera.2007.08.003","article-title":"The pharmacological exploitation of cholesterol 7alpha-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol","volume":"116","author":"Gilardi","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2016.05.001_bb0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.envres.2014.10.004","article-title":"Associations of perfluorinated chemical serum concentrations and biomarkers of liver function and uric acid in the US population (NHANES), 2007-2010","volume":"136","author":"Gleason","year":"2015","journal-title":"Environ. Res."},{"key":"10.1016\/j.taap.2016.05.001_bb0135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.gdata.2015.05.037","article-title":"Global Gene expression changes in liver following hepatocyte nuclear factor 4 alpha deletion in adult mice","volume":"5","author":"Gunewardena","year":"2015","journal-title":"Genom Data"},{"key":"10.1016\/j.taap.2016.05.001_bb0140","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","article-title":"Claudins and the modulation of tight junction permeability","volume":"93","author":"Gunzel","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2016.05.001_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-5793(01)02423-1","article-title":"Hepatic maturation in differentiating embryonic stem cells in vitro","volume":"497","author":"Hamazaki","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2016.05.001_bb0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1369\/0022155413479123","article-title":"Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas","volume":"61","author":"Holczbauer","year":"2013","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.taap.2016.05.001_bb0155","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.coph.2010.08.010","article-title":"HNF4alpha\u2013role in drug metabolism and potential drug target?","volume":"10","author":"Hwang-Verslues","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.taap.2016.05.001_bb0160","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1053\/j.gastro.2007.02.046","article-title":"Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide","volume":"132","author":"Imai","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2016.05.001_bb0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbrc.2004.01.038","article-title":"Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet","volume":"315","author":"Kawaguchi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2016.05.001_bb0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/10408440490464705","article-title":"The toxicology of perfluorooctanoate","volume":"34","author":"Kennedy","year":"2004","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0175","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/01480545.2011.582502","article-title":"Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate\/sulfonate (PFOA\/PFOS) in the C8 health project","volume":"34","author":"Kerger","year":"2011","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0180","doi-asserted-by":"crossref","first-page":"41334","DOI":"10.1074\/jbc.M112.421834","article-title":"Nuclear receptors HNF4alpha and LRH-1 cooperate in regulating Cyp7a1 in vivo","volume":"287","author":"Kir","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2016.05.001_bb0185","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/713608372","article-title":"PPARalpha agonist-induced rodent tumors: modes of action and human relevance","volume":"33","author":"Klaunig","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0190","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.reprotox.2011.10.014","article-title":"Mode of action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and human relevance","volume":"33","author":"Klaunig","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2131\/jts.28.49","article-title":"Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals","volume":"28","author":"Kudo","year":"2003","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.taap.2016.05.001_bb0200","first-page":"14","article-title":"Biomonitoring for perfluorochemicals in a Minnesota community with known drinking water contamination","volume":"77","author":"Landsteiner","year":"2014","journal-title":"J. Environ. Health"},{"key":"10.1016\/j.taap.2016.05.001_bb0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.reprotox.2012.03.002","article-title":"Perfluoroalkyl acids: recent research highlights","volume":"33","author":"Lau","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.taap.2016.05.001_bb0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/toxsci\/kfg122","article-title":"Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation","volume":"74","author":"Lau","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2016.05.001_bb0215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.taap.2003.11.031","article-title":"The developmental toxicity of perfluoroalkyl acids and their derivatives","volume":"198","author":"Lau","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2016.05.001_bb0220","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/toxsci\/kfj105","article-title":"Effects of perfluorooctanoic acid exposure during pregnancy in the mouse","volume":"90","author":"Lau","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2016.05.001_bb0225","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/hep.20155","article-title":"Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors","volume":"39","author":"Lazarevich","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2016.05.001_bb0230","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.1021\/es2011622","article-title":"Polyfluorinated compounds: past, present, and future","volume":"45","author":"Lindstrom","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.taap.2016.05.001_bb0235","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.taap.2016.05.001_bb0240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/MCB.00927-09","article-title":"Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism","volume":"30","author":"Martinez-Jimenez","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2016.05.001_bb0245","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.humpath.2013.12.002","article-title":"Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions","volume":"45","author":"Matkowskyj","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.taap.2016.05.001_bb0250","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1096\/fj.10-173716","article-title":"Role for PPARgamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts","volume":"25","author":"Moran-Salvador","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2016.05.001_bb0255","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1073\/pnas.96.2.511","article-title":"Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands","volume":"96","author":"Morita","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2016.05.001_bb0260","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1158\/0008-5472.CAN-10-0824","article-title":"Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma","volume":"70","author":"Ning","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2016.05.001_bb0265","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s13105-011-0110-6","article-title":"Role of lipid droplet proteins in liver steatosis","volume":"67","author":"Okumura","year":"2011","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.taap.2016.05.001_bb0270","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2016.05.001_bb0275","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/gb-2008-9-1-r19","article-title":"Translational control plays a prominent role in the hepatocytic differentiation of HepaRG liver progenitor cells","volume":"9","author":"Parent","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.taap.2016.05.001_bb0280","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng1175","article-title":"Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis","volume":"34","author":"Parviz","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2016.05.001_bb0285","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.taap.2016.05.001_bb0290","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype","volume":"110","author":"Pullinger","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2016.05.001_bb0295","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tox.2009.03.009","volume":"260","author":"Qazi","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2016.05.001_bb0300","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.intimp.2010.08.009","article-title":"Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice","volume":"10","author":"Qazi","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2016.05.001_bb0305","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/toxsci\/kfn025","article-title":"Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR","volume":"103","author":"Rosen","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2016.05.001_bb0310","article-title":"Gene expression profiling in wild-type and PPARalpha-null mice exposed to perfluorooctane sulfonate Reveals PPARalpha-independent effects","author":"Rosen","year":"2010","journal-title":"PPAR Res. 2010"},{"key":"10.1016\/j.taap.2016.05.001_bb0315","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.0706736104","article-title":"Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis","volume":"104","author":"Sanyal","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2016.05.001_bb0320","doi-asserted-by":"crossref","first-page":"E1195","DOI":"10.1152\/ajpendo.00513.2004","article-title":"PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes","volume":"288","author":"Schadinger","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2016.05.001_bb0325","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.toxlet.2012.05.007","article-title":"Perfluorooctanoic acid affects the activity of the hepatocyte nuclear factor 4 alpha (HNF4alpha)","volume":"212","author":"Scharmach","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2016.05.001_bb0330","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2166\/wst.2009.504","article-title":"Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper","volume":"60","author":"Suja","year":"2009","journal-title":"Water Sci. Technol."},{"key":"10.1016\/j.taap.2016.05.001_bb0335","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bbalip.2011.10.016","article-title":"Roles of PPARs in NAFLD: potential therapeutic targets","volume":"1821","author":"Tailleux","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2016.05.001_bb0340","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1021\/es900228k","article-title":"Tracking the pathways of human exposure to perfluorocarboxylates","volume":"43","author":"Vestergren","year":"2009","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.taap.2016.05.001_bb0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3727\/105221615X14181438356292","article-title":"Role of hepatocyte nuclear factor 4alpha (HNF4alpha) in cell proliferation and cancer","volume":"16","author":"Walesky","year":"2015","journal-title":"Gene Expr."},{"key":"10.1016\/j.taap.2016.05.001_bb0350","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/hep.26251","article-title":"Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents","volume":"57","author":"Walesky","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2016.05.001_bb0355","doi-asserted-by":"crossref","first-page":"G26","DOI":"10.1152\/ajpgi.00064.2012","article-title":"Hepatocyte-specific deletion of hepatocyte nuclear factor-4alpha in adult mice results in increased hepatocyte proliferation","volume":"304","author":"Walesky","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.taap.2016.05.001_bb0360","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/jhep.2003.50273","article-title":"HNF4: a central regulator of hepatocyte differentiation and function","volume":"37","author":"Watt","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2016.05.001_bb0365","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0969-2126(02)00829-8","article-title":"Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids","volume":"10","author":"Wisely","year":"2002","journal-title":"Structure"},{"key":"10.1016\/j.taap.2016.05.001_bb0370","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.taap.2014.05.010","article-title":"Mechanisms of acetaminophen-induced cell death in primary human hepatocytes","volume":"279","author":"Xie","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2016.05.001_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005609","article-title":"Identification of an endogenous ligand bound to a native orphan nuclear receptor","volume":"4","author":"Yuan","year":"2009","journal-title":"PLoS ONE"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X16301016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X16301016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T10:22:43Z","timestamp":1536747763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X16301016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":75,"alternative-id":["S0041008X16301016"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2016.05.001","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}